The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.20
Bid: 69.00
Ask: 69.20
Change: 0.60 (0.87%)
Spread: 0.20 (0.29%)
Open: 68.60
High: 69.20
Low: 68.40
Prev. Close: 68.60
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scrip Share Reference Price

8 Nov 2018 07:00

RNS Number : 6943G
GCP Asset Backed Income Fund Ltd
08 November 2018
 

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815

Scrip Share Reference Price

8 November 2018

GCP Asset Backed, which invests in asset backed loans, today announces the reference price of a new ordinary share under the scrip dividend alternative for the period 1 July 2018 to 30 September 2018 (the "Q3 Dividend") of 105.25 pence (the "Scrip Reference Price").

On the basis of the Scrip Reference Price and the price per share of the Q3 Dividend, a holder of 69 ordinary shares will receive 1 new ordinary share.

The Scrip Reference Price was calculated by taking the average of the Company's closing middle market quotations of an ordinary share for the ex-dividend date of 1 November 2018 and the four subsequent dealing days.

Further details of the scrip dividend alternative can be found in the Scrip Dividend Circular 2018 which was published by the Company on 26 April 2018, a copy of which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.graviscapital.com/funds/gcp-asset-backed/literature.

The Q3 Dividend payment date and the date for admission and dealing of the new ordinary shares to be issued pursuant to the scrip dividend alternative is expected to be 30 November 2018.

 

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon david.conlon@graviscapital.com

Dion Di Miceli dion.dimiceli@graviscapital.com

Cenkos Securities plc +44 (0) 20 7397 8900

Tom Scrivens tscrivens@cenkos.com

Oliver Packard opackard@cenkos.com

Sapna Shah sshah@cenkos.com

 

Notes to editors

GCP Asset Backed is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVZMMGMRNGGRZM
Date   Source Headline
14th Dec 20232:58 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
14th Dec 20232:44 pmRNSForm 8.3 - GCP Asset Backed Income Fund Limited
14th Dec 20232:01 pmGNWForm 8.3 - GCP Asset Backed Income Fund Ltd
14th Dec 20231:48 pmRNSForm 8 (OPD) GCP Asset Backed Income Fund Limited
14th Dec 202311:56 amRNSForm 8.3 - GCP Asset Backed Income Fund Limited
13th Dec 20235:11 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
13th Dec 20232:00 pmRNSForm 8.3 - GCP Asset Backed Income Fund Ltd
13th Dec 20237:00 amRNSStrategic Review
13th Nov 20237:00 amRNSInvestor report at 30 September 2023
8th Nov 20237:00 amRNSDividend Declaration
20th Oct 20237:00 amRNSQuarterly Update
16th Oct 20237:00 amRNSChange of Corporate Broker
28th Sep 20237:00 amRNSHalf-year Report & Financial Statements
18th Sep 20237:00 amRNSCessation of combination discussions
24th Aug 20237:00 amRNSInvestor Report at 30 June 2023
11th Aug 20237:02 amRNSProposed Combination
20th Jul 20237:00 amRNSQuarterly update and dividend declaration
7th Jul 20237:00 amRNSExtension to term of Revolving Credit Facility
30th Jun 20235:52 pmRNSTotal Voting Rights
23rd Jun 20235:17 pmRNSTransaction in Own Shares
16th Jun 20235:23 pmRNSTransaction in Own Shares
15th Jun 20235:17 pmRNSTransaction in Own Shares
14th Jun 20235:25 pmRNSTransaction in Own Shares
9th Jun 20235:09 pmRNSTransaction in Own Shares
8th Jun 20235:23 pmRNSTransaction in Own Shares
6th Jun 20235:14 pmRNSTransaction in Own Shares
2nd Jun 20235:22 pmRNSTransaction in Own Shares
1st Jun 20235:38 pmRNSTransaction in Own Shares
31st May 20235:47 pmRNSTotal Voting Rights
31st May 20235:46 pmRNSTransaction in Own Shares
30th May 20235:17 pmRNSTransaction in Own Shares
26th May 20235:28 pmRNSTransaction in Own Shares
25th May 20235:35 pmRNSTransaction in Own Shares
23rd May 20235:26 pmRNSTransaction in Own Shares
23rd May 202311:13 amRNSInvestment Manager Resourcing Update
19th May 20235:27 pmRNSTransaction in Own Shares
18th May 20235:32 pmRNSTransaction in Own Shares
17th May 20235:29 pmRNSTransaction in Own Shares
16th May 20235:49 pmRNSTransaction in Own Shares
15th May 20234:25 pmRNSResult of AGM
5th May 20237:00 amRNSInvestor report at 31 March 2023
3rd May 20237:00 amRNSDividend Declaration
28th Apr 20235:22 pmRNSTotal Voting Rights
28th Apr 20239:00 amRNSChange of Registered Office
25th Apr 20237:00 amRNSQuarterly Update
20th Apr 20239:15 amRNSNotice of AGM
14th Apr 20237:00 amRNSAnnual report and financial statements
31st Mar 20235:20 pmRNSTotal Voting Rights
29th Mar 20235:25 pmRNSTransaction in Own Shares
28th Mar 20235:23 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.